Grantham, Mayo, Van Otterloo & Co (GMO)’s Leidos LDOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.03M Buy
58,513
+27,491
+89% +$3.65M 0.01% 306
2026
Q1
$4.82M Sell
31,022
-3,576
-10% -$642K 0.01% 331
2025
Q4
$6.24M Buy
34,598
+7,424
+27% +$1.41M 0.02% 282
2025
Q3
$5.13M Sell
27,174
-14,396
-35% -$2.51M 0.01% 291
2025
Q2
$6.56M Sell
41,570
-2,974
-7% -$440K 0.02% 268
2025
Q1
$6.01M Buy
44,544
+25,614
+135% +$3.58M 0.02% 288
2024
Q4
$2.73M Sell
18,930
-3,805
-17% -$633K 0.01% 350
2024
Q3
$3.71M Buy
22,735
+1,677
+8% +$254K 0.01% 341
2024
Q2
$3.07M Buy
21,058
+4,628
+28% +$647K 0.01% 339
2024
Q1
$2.15M Buy
+16,430
New +$1.96M 0.01% 358
2022
Q3
Sell
-133,400
Closed -$13.4M 757
2022
Q2
$13.4M Sell
133,400
-45,800
-26% -$4.75M 0.07% 220
2022
Q1
$19.4M Sell
179,200
-20,600
-10% -$1.99M 0.09% 182
2021
Q4
$17.8M Sell
199,800
-2,000
-1% -$187K 0.09% 185
2021
Q3
$19.4M Buy
201,800
+1,300
+0.6% +$129K 0.1% 175
2021
Q2
$20.3M Buy
200,500
+46,864
+31% +$4.81M 0.1% 170
2021
Q1
$14.8M Buy
153,636
+86,536
+129% +$8.74M 0.08% 188
2020
Q4
$7.05M Buy
+67,100
New +$6.43M 0.04% 247
2018
Q3
Sell
-4,200
Closed -$248K 563
2018
Q2
$248K Sell
4,200
-52,400
-93% -$3.27M ﹤0.01% 525
2018
Q1
$3.7M Sell
56,600
-5,800
-9% -$383K 0.02% 263
2017
Q4
$4.03M Sell
62,400
-8,200
-12% -$514K 0.02% 257
2017
Q3
$4.18M Sell
70,600
-16,600
-19% -$925K 0.02% 241
2017
Q2
$4.51M Buy
87,200
+83,000
+1,976% +$4.42M 0.02% 252
2017
Q1
$215K Buy
+4,200
New +$216K ﹤0.01% 537
2014
Q1
Sell
-8,709
Closed -$405K 603
2013
Q4
$405K Buy
+8,709
New +$402K ﹤0.01% 581

Other funds holding LDOS

Grantham, Mayo, Van Otterloo & Co (GMO)'s LDOS Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Leidos (LDOS) stake by 89% in Q2 2026, buying an estimated $3.65M and bringing the position to 58,513 shares worth $6.03M. The position accounts for 0.01% of the portfolio, ranked #306.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LDOS in Q4 2013 and has held it in 24 quarters since. The position peaked at $20.3M in Q2 2021. 767 funds tracked by Wall St. Rank hold LDOS as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 58,513 shares of Leidos worth $6.03M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 27,491 Leidos shares in Q2 2026, an estimated $3.65M.
  • Leidos made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #306 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Leidos in Q4 2013 and has held it in 24 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Leidos position peaked at $20.3M in Q2 2021.
  • 767 funds tracked by Wall St. Rank held Leidos as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.